In this meta-analysis, we identified 14 eligible studies, including 5647 lung cancer cases and 6908 controls, and analyzed the relationship between XPC Lys939Gln, Ala499Val, and PAT polymorphisms and susceptibility to lung cancer. Here, XPC is linked to lung cancer.